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normal women at high risk for Alzheimer's disease
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bMagnetic Resonance Imaging and Spectroscopy Center, University of Kentucky, Lexington, KY
40536
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Abstract
There is evidence that disruption of white matter (WM) microstructure is an early event in the
course of Alzheimer’s disease (AD). However, the neurobiological bases of WM microstructural
declines in presymptomatic AD are unknown. In the present study we address this issue using a
multimodal imaging approach to the study of presymptomatic AD. Participants were 37 high risk
(both family history of dementia and one or more APOE4 alleles) women and 20 low risk (neither
family history nor APOE4) women. Groups were matched for age, education, neuropsychological
performance, and vascular factors that could affect white matter. Whole-brain analyses of
diffusion tensor imaging data [including fractional anisotropy (FA), mean diffusivity (MD), axial
diffusivity (DA) and radial diffusivity (DR)] and volumetric comparisons of medial temporal lobe
(MTL) structures were conducted. Results indicated equivalent entorhinal cortex and hippocampal
volumes between risk groups. Nevertheless, the high risk group showed decreased microstructural
integrity in WM tracts with direct and secondary connections to the MTL. The predominant
alteration in WM integrity in the high AD-risk group was decreased FA not solely driven by either
DA or DR changes alone in regions where no MD changes were observed. A second pattern
observed in a smaller number of regions involved decreased FA and increased DR. These results
suggest that disconnection of MTL-neocortical fiber pathways represents a very early event in the
course of AD and suggest that demyelination may represent one contributing mechanism.
Keywords
diffusion tensor; fractional anisotropy; magnetic resonance imaging; Alzheimer's disease;
apolipoprotein E; myelin
Introduction
Alzheimer’s disease (AD) has traditionally been viewed as a disease of grey matter – a
neuronal/synaptic polioencephalopathy. However, there is pathological evidence that
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disruption of white matter (WM) microstructure is an early event in the course of AD (Brun
and Englund, 1986; Englund et al., 1988). Concordant with this pathology data, evidence of
WM disruption in AD has been demonstrated by non-invasive diffusion tensor imaging
(DTI) (reviewed in Stebbins and Murphy, 2009). DTI is sensitized to the random motion of
water molecules as they interact within tissues, thus reflecting characteristics of their
immediate structural surroundings. In WM, the motion of water molecules is hindered more
in directions orthogonal to the main fiber direction than along the fiber, and thus diffusion
tends to be anisotropic. Diffusion anisotropy can be measured by DTI by means of fractional
anisotropy, an index of overall tissue microstructural integrity (Pierpaoli and Basser, 1996).
A body of data from DTI studies has demonstrated that reduced WM integrity is not only
evident in the frontal, temporal and parietal lobes of individuals with AD, but also in its
typical early prodromal state of mild cognitive impairment (MCI) (reviewed in Stebbins and
Murphy, 2009).
These findings have motivated the question of whether WM microstructural changes are
present in cognitively normal individuals at high risk for future AD, a potential target group
for emerging interventions. Several recent studies have demonstrated that individuals at high
risk for future AD based on an apolipoprotein-E4 (APOE4) allele show reduced fractional
anisotropy (FA) in certain brain regions compared to low risk groups (Nierenberg et al.,
2005; Persson et al., 2006; Smith et al., 2008). These studies used manual region-of-interest
(ROI) tracing (Nierenberg et al., 2005), voxel-based morphometry (Persson et al., 2006) or
tract-based spatial statistics implemented in FSL software (Smith et al., 2008). In general,
the decreases in WM integrity reported in these studies of normal subjects were of smaller
magnitude and more confined to tracts associated with medial temporal lobe structures than
observed in studies of AD subjects. For example, presymptomatic AD studies have reported
reduced FA in the cingulum (Persson et al., 2006; Smith et al., 2008), parahippocampal WM
(Nierenberg et al., 2005; Persson et al., 2006; Smith et al., 2008) and inferior longitudinal
fasciculus (Smith et al., 2008). These data suggest that changes in WM integrity precede
cognitive decline in AD, which may prove important for early AD detection by non-invasive
imaging.
However, there currently exist at least two knowledge gaps concerning WM microstructural
declines in presymptomatic AD, resulting from the fact that previous DTI studies of WM
integrity in presymptomatic AD have focused almost exclusively on the FA metric. One
resulting knowledge gap concerns whether WM microstructural changes in presymptomatic
AD are independent of or secondary to classically described grey matter medial temporal
lobe (MTL) degeneration. Neuropathology affects the hippocampus and entorhinal cortex
(ERC) early in the course of AD (Braak and Braak, 1991; Hyman et al., 1984), and atrophy
of these MTL structures is evident with MR imaging early in the AD disease process
(Convit et al., 1997; de Leon et al., 2004; Jack et al., 1997). In addition, recent results
suggest that hippocampal and ERC volumes can be reduced in presymptomatic AD, several
years prior to MCI diagnosis (Martin et al., 2008; Smith et al., 2007). It is thus important for
studies of WM integrity to assess MTL volume and to determine its potential contribution to
reduced integrity of MTL WM tracts in presymptomatic AD.
A second knowledge gap concerns the pattern of diffusivity characteristics beyond FA that
characterize presymptomatic AD. The FA metric represents a weighted average of distinct
components of the diffusion tensor and provides an overall assessment of WM integrity
(Pierpaoli and Basser, 1996). However, a comprehensive understanding of WM
microstructural declines requires joint consideration of FA, mean diffusivity, radial
diffusivity, and axial diffusivity (Assaf and Pasternak, 2008; Burzynska et al., 2009). Mean
diffusivity (MD) is an average of all three eigenvalues of the diffusion tensor and depends
on the density of physical obstructions such as membranes and the distribution of water
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molecules between different cell compartments (Beaulieu, 2002; Sen and Basser, 2005). The
diffusion tensor can also be decomposed into three mutually orthogonal eigenvectors. In
particular, the tensor can be separated to reflect the diffusion coefficient along the direction
of maximal ‘apparent’ diffusion (λ1 or ‘axial diffusivity’), and the diffusion coefficients
along two orthogonal directions embedded in the plane perpendicular to the main diffusion
direction (λ2 and λ3). The second and third eigenvalues can be averaged and expressed as
‘radial diffusivity’. These component (axial and radial) diffusivities have been linked with
different underlying pathologies (Song et al., 2002; Sen and Basser, 2005).
One way to begin to characterize the neurobiological bases of recently described FA
decreases in presymptomatic AD would be to identify group differences in MD, DR, and
DA within regions showing FA decreases. This approach allows for a more detailed
understanding about WM integrity decline than separate consideration of FA, MD, DR and
DA (Assaf and Pasternak, 2008; Burzynska et al., 2009). For example, a finding of increased
MD in regions showing decreased FA would suggest reductions in microstructural integrity
that are in part associated with macroscopic tissue loss and increased brain water content
(Sen and Basser, 2005). In contrast, decreased FA without increased MD suggests
microstructural changes to WM fibers that are not due to gross tissue loss (Sen and Basser,
2005). A reduction in FA along with increased DR has been linked with loss of myelin in
multiple sclerosis (Ciccarelli et al., 2006) and in animal studies of experimentally induced
myelin loss (Song et al., 2002; Song et al., 2005; Sun et al., 2006). Finally, a decrease in FA
and DA without a DR increase has been reported in both rodents and humans with axonal
damage associated with axonal swelling, fragmentation and organelle accumulations
(Concha et al., 2006; Sun et al., 2006).
In the present exploratory study we address these two knowledge gaps concerning WM
integrity reductions in presymptomatic AD using a multimodal imaging approach. We first
assessed the macrostructural integrity (i.e., volume) of the two MTL regions which have
been classically linked with AD pathology and MRI-based brain atrophy: the ERC and
hippocampus. Next we assessed the pattern of WM microstructural changes associated with
being at high risk for AD. In particular, we sought to provide information about potential
neurobiological bases of decreased WM decline in presymptomatic AD through assessment
of the combined pattern of whole-brain changes in FA, MD, DA and DR. Finally, we
assessed the relationship between these WM metrics and hippocampal volume.
Methods
Participants
Participants were 37 high risk (both family history of dementia and one or more APOE4
alleles) women and 20 low risk (neither family history nor APOE4) women who ranged in
age from 50 to 70 years old (Table 1). All participants in the present study are involved in a
larger ongoing University of Kentucky longitudinal imaging study of normal persons who
vary in their risk of AD based on family history of dementia and APOE allele status (Smith
et al., 2008). Only right-handed females are recruited for the larger longitudinal imaging
study, from which the present subjects were drawn, because the comprehensive imaging
protocol includes functional magnetic resonance imaging of language-based tasks, a
cognitive domain in which gender and handedness can influence activation. Participants in
the present study were selected from the larger cohort on the basis of (1) having an available
DT image; (2) age (in order to match groups for mean age) and (3) the absence of any
detectable vascular pathology (small or large vessel infarcts, microhemorrhages, or
significant periventricular hyperintensities). The FA data of some of the present subjects
have been reported in a previous study (Smith et al., 2008).
Gold et al. Page 3
Neuroimage. Author manuscript; available in PMC 2011 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Inclusion criteria other than sex and handedness in the imaging protocol include generally
good health without memory complaints, stable medication regimen, being between the age
of 40 and 90 years, vision correctable to at least 20/50, and knowledge of family history.
Family history is considered positive if one or more first degree relatives had late-onset
dementia. Exclusions are stroke or other cerebral injury, psychoactive medications, except
stable doses of serotonin reuptake inhibitors, active depression, significant head injury
(operationally defined as a loss of consciousness greater than five minutes), significant
psychiatric history, claustrophobia, metallic implants in the head or neck, pacemakers, major
surgery within three months, or death of one or both parents before age 65.
Participants from either risk group who are selected for scanning undergo standardized
psychometric testing which includes the Mini Mental State Examination (MMSE), Trails A
and B, FAS Letter Fluency (LF), Wechsler Adult Intelligence Scale (WAIS ) Block Design
(Block Des) and Vocabulary (Vocab), 15-item Boston Naming Test (BNT), Wechsler
Memory Scale (WMS) Logical Memory I (LM Imm) and II (LM Del), Visual Reproduction
immediate and delayed (VR Imm and VR Del), Digit Span (DS), Spatial Span (SS),
Selective Reminding Test Immediate and Delayed (SRT Imm & SRT Del), and the Beck
depression inventory (Beck). Abbreviations are given for reference to Table 1. These tests
are given to exclude persons with cognitive impairment and to document equivalent normal
cognitive performance between risk groups. All subjects had an APOE allele determination,
using polymerase chain reaction (PCR) amplification followed by enzymatic digestion and
separation of DNA fragments by agarose gel electrophoresis. Informed consent was
obtained from each enrollee under an approved University of Kentucky Medical Institutional
Review Board protocol.
MRI Acquisition Procedures
Data were collected on a 3 Tesla Siemens Trio scanner at the University of Kentucky. An 8-
channel imaging coil was used. Comfortable, disposable foam earplugs were used to
dampen scanner noise. Comfortable foam padding was used to limit head motion within the
coil and to further dampen scanner noise.
Diffusion Tensor Imaging (DTI) Acquisition—Whole-brain (40 slices) diffusion
tensor images were acquired with 3 averages in each of 12 encoding directions (B0 images
were averaged 6 times; TR = 14600 ms, TE= 96 ms; resolution 1.8 × 1.8 × 3.0 mm) using a
fluid attenuated inversion recovery (FLAIR) double-refocused spin echo sequence.
Structural MRI—Participants underwent structural MRI during the same scanning session
as diffusion-weighted imaging. A three-dimentional magnetization-prepared rapid gradient
echo (MP-RAGE) sequence was used with parameters: repetition time (TR) = 2100 ms,
echo time (TE) = 2.93 ms, inversion time (TI) = 1100 ms, flip angle = 12°, field of view
(F.O.V.) = 224×256×192 mm, sagittal partitions, yielding isotropic 1 mm3 voxels.
MRI Analysis Procedures
Hippocampal and ERC volumes—FreeSurfer software
(http://surfer.nmr.mgh.harvard.edu) was used for cortical parcellation (Desikan et al., 2006;
Fischl et al., 2004b) and subcortical segmentation (Fischl et al., 2002; Fischl et al., 2004a).
The standard data processing stream in FreeSurfer involves intensity normalization for
removal of the B1 bias field, skull stripping, and Markov random field modeling for
segmentation and gray matter volume labeling, incorporating atlas-based anatomical class
priors. Individual structure volumes are in turn computed from labeled voxels and
normalized to total intracranial volume (ICV).
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DTI preprocessing—T2 Images were inspected for visible WM hyperintensities by an
experienced neurologist (Dr. Charles Smith). Diffusion volumes were motion corrected and
averaged using the Linear Image Registration Tool in FSL software (FLIRT:
http://www.fmrib.ox.ac.uk/fsl). Corrections for motion and residual eddy current distortion
were performed using a 12-parameter affine transformation of the images from each
direction to the minimally eddy current distorted T2-weighted DTI volume that has no
diffusion weighting.
Fractional anisotropy and diffusivity map calculations—Each participant’s
voxelwise diffusion tensor was calculated using nonlinear estimation (Basser and Pierpaoli,
1996). Maps for FA, mean diffusivity (MD), axial diffusivity (DA) and radial diffusivity
(DR) were extracted using procedures described elsewhere (Basser et al., 1994). Briefly, for
FA maps, three eigenvectors that define the diffusion ellipsoid were calculated in each voxel
from the diffusion tensor. These eigenvectors correspond to three eigenvalues, which
represent the magnitude of diffusivity in the three principal directions relative to the
maximum in each voxel. Thus the diffusion tensor is based on directions and magnitudes of
diffusivity within the brain, independent of scanner coordinates. Based upon the three
principal diffusivities, FA is calculated in each voxel (Basser and Pierpaoli, 1996). Mean
diffusivity is a scalar measure of the total amount of diffusion within a voxel and was
calculated as described in Basser and Pierpaoli (1996). Measures of axial (λ1) and radial [(λ2
+ λ3)/2] diffusivity were computed as described in Song et al. (2002).
Nonlinear Registration of FA and Diffusivity Maps into Standard Space—
Registration of FA images into MNI152 space and subsequent voxelwise analyses followed
a series of procedures known as Tract-Based Spatial Statistics [TBSS v1.2; (Smith et al.,
2006)], part of the publicly available image processing software FSL 4.0
(http://www.fmrib.ox.ac.uk/fsl/tbss/). TBSS was used because its algorithms for alignment
of FA images from multiple subjects into a common space have been extensively tested and
validated [Smith et al., 2006]. In addition, the technique does not require spatial smoothing
of images, which can produce different results depending upon the kernel size (Jones et al.,
2005). All subjects’ FA images were first aligned to a common registration target (the image
to which the least amount of warping was required for all other subjects to align to it) using
a nonlinear registration approach based on free-form deformations and B-Splines (Rueckert
et al., 1999). FA datasets were then affine registered and resampled to 1 × 1 × 1 mm
MNI152 space. The exact transformations derived from the FA maps were then applied to
the other diffusivity maps (MD/DR/DA) for matched processing of all image volumes. All
subsequent processing was carried out in this standardized space.
The MNI-transformed FA images from all subjects were averaged to create a mean FA
image. The mean FA image was then entered into the tract skeleton generator, which
calculates a tract representation ‘common’ to all participants. The tract skeleton was then
thresholded at an FA value of 0.2 in order to exclude regions that likely comprise multiple
tissue types or fiber orientations. Each participant’s aligned FA image was subsequently
projected onto the FA skeleton in order to account for residual misalignments between
participants after the initial nonlinear registration. This effectively aligns each participant’s
FA image with the skeleton and is achieved for each skeleton voxel by searching
perpendicular to the local skeleton structure for the maximum value in the subject’s FA
image. The result is a common tract skeleton with each subject’s FA image aligned to this
common skeleton. The skeleton is thus filled with each participant’s FA values from the
centers of the nearest relevant tracts. Thus, the data are in the form of a sparse 4 D image,
with the fourth dimension being subject ID. Each subject’s MD, DA and DR maps in MNI
space were then projected onto the common tract skeleton, using the pipeline for non-FA
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data provided by TBSS, which employs the projection vectors from each individual’s FA-to-
skeleton transformation (Smith et al., 2006).
A statistical threshold of P < 0.001 (uncorrected) was employed for separate between-group
comparisons of FA, MD and component diffusivity (DR and DA). The main purpose of
these analyses was to characterize the potential neurobiological bases of FA changes
previously reported in presymptomatic AD. Group difference maps of MD, DR and DA
were thus masked by regions showing decreased FA in the high risk group (there were no
regions of decreased FA in the low risk group). Restricting between-group analyses of MD/
DR/DA maps to voxels showing decreased FA in the high risk group also served to reduce
the type I error risk by reducing the number of comparisons performed. Age was included as
a covariate in all WM integrity analyses (FA/MD/DR/DA). All statistical maps were dilated
from the TBSS skeleton for visualization purposes.
Results
Demographic and psychometric scores were compared between risk groups (Table 1). The
high and low AD-risk groups of women did not differ in mean age or education. Because no
correction was made for the 14 multiple comparisons associated with the psychometric test
scores in Table 1, we chose to conservatively interpret a P-value between 0.01 and 0.05 as
indicating marginal significance, and a P-value less than 0.01 as significant. None of the 14
psychometric tests met our threshold P-value of <0.01 for risk group difference. The high
AD-risk group scored lower on the letter fluency test and this difference was marginally
significant (P = 0.03).
To test for potential differences between risk groups related to vascular factors or estrogen
replacement that might affect white matter, Chi-Square analysis using Pearson's criterion
without correction for multiple comparisons was performed on the following categorical
variables (Present/Not Present): current smoking, past smoking, current estrogen
replacement, past estrogen replacement, hypercholesterolemia, hypertension and diabetes.
There were three subjects with stable diabetes in the study, one in the low and two in the
high AD-risk group. None of the P-values in these comparisons was less than P = 0.40,
demonstrating that the frequencies of these factors were the same between risk groups.
Hippocampus and Entorhinal Cortex Volume
Figure 1 displays the mean hippocampal and entorhinal cortex volumes in normal high and
low AD-risk groups. Separate ANCOVAs were conducted with MTL volume (hippocampal
or ERC) as the dependent variable, risk group as the independent variable of interest and age
and ICV as covariates of no interest. Because there were no hemisphere by risk group
interactions in either MTL ROI volume (both F’s < 1.0), the average (left-right)
hippocampal and ERC volumes were entered into between-group comparisons. The high
and low AD-risk groups did not differ in hippocampus volume, F(1, 53) = 0.12 for P = 0.73,
or in ERC volume F(1, 53) = 0.42 for P = 0.52.
White Matter Microstructural Integrity
Figure 2 presents the results from the group comparisons of FA and MD. The anatomic
underlay is the MNI-space registered target FA image. Maps are referenced to a standard
human white matter atlas (Mori et al., 2005). The high AD-risk group showed decreased FA
(shown in red) compared to the low risk group in a number of regions, prominently
including the fornix and inferior longitudinal fasciculus (ILF) in the temporal lobe and
anterior portions of the inferior fronto-occipital fasciculus (IFOF) / uncinate fasciculus
(UNC) in the frontal lobe. There were no regions in which the low AD-risk group showed
Gold et al. Page 6
Neuroimage. Author manuscript; available in PMC 2011 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
decreased FA compared to the high risk group. Within regions of decreased FA, there were
only two regions of increased MD in the high risk group (shown in orange): the genu and the
right IFOF/ILF.
Figure 3 presents the results from the comparison of component diffusivities [radial
diffusivity (DR) and axial diffusivity (DA)] within regions showing group-based FA
differences. Within regions of decreased FA in the high AD-risk group, the majority of
component diffusivity changes were characterized by increased DR. Regions showing
increased DR in the high risk group (shown in blue) were bilateral portions of the ILF in the
temporal lobe and bilateral portions of the IFOF / UNC in the frontal lobe. In contrast, there
were only a few small regions in which the high risk group showed altered DA compared to
the low risk groups. The high risk group showed decreased DA compared to the low risk
group (shown in yellow) in a rostral portion of the cingulum. Finally, the high risk group
showed decreased DA in only a few scattered voxels (not shown).
One of the regions showing decreased WM integrity in the high risk group, the fornix,
represents the principal efferent pathway of the hippocampus. Despite the equivalence of
hippocampal volume between groups, within-group variability in hippocampal volume
could affect the size of WM microstructural effects in the fornix or other MTL tracts. This
possibility was explored in a set of supplementary analyses which considered the effects of
including normalized hippocampal volume as a covariate in the group comparisons of FA/
MD/DR/DA. Including normalized hippocampal volume as a covariate had minimal effects
on the between-group WM microstructural results and did not alter the finding of reduced
FA in the fornix in the high AD-risk group (Figure 4). Rather, controlling for hippocampal
volume revealed an additional effect of reduced FA (and increased DR) in the high AD-risk
group in the caudal portion of the left cingulum, a tract with direct connections between the
MTL and posterior cingulate cortex.
Discussion
Our results demonstrate white matter (WM) microstructural integrity reductions in normal
individuals at high risk for Alzheimer’s disease (AD) in the absence of medial temporal lobe
(MTL) atrophy. Reductions of microstructural integrity of MTL fiber tracts, in addition to
other pathways, have been reported in previous DTI studies of MCI/AD (reviewed in
Stebbins and Murphy, 2009). However, atrophy of the entorhinal cortex (ERC) and
hippocampus is observed in MCI/AD (Convit et al., 1997; de Leon et al., 2004; Jack et al.,
1997) and may have contributed to the reduced integrity of MTL tracts observed in previous
studies. The present results demonstrate that WM microstructural integrity reductions in
tracts with direct and secondary connections to MTL structures are not merely a
consequence of classic AD-related ERC/hippocampal atrophy and may precede macroscopic
degeneration in these regions.
The WM tracts showing decreased integrity in presymptomatic AD represent connections
among structures involved in episodic memory function (Colchester et al., 2001). The high
AD-risk group showed decreased fractional anisotropy (FA) in the fornix, cingulum, inferior
longitudinal fasciculus (ILF) and rostral portions of the inferior fronto-occipital fasciculus
(IFOF). The fornix is the major efferent tract of the hippocampus, connecting it with the
septal frontal region, the mamillary bodies of the hypothalamus, and the anterior nuclei of
the thalamus. The caudal portion of the cingulum contains fibers that connect the posterior
cingulate cortex with the hippocampus and parahippocampal gyrus (Mufson and Pandya,
1984). The ILF contains connections between occipital and temporal regions, and the IFOF
contains connections between occipital regions and ventrolateral prefrontal cortex (Catani et
al., 2002). Both the ILF and IFOF have secondary connections to the MTL (Catani et al.,
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2002). Our results using in vivo DT imaging are consistent with pathological data suggesting
that limbic-neocortical pathways are preferentially affected early in AD (Braak and Braak,
1996).
Joint consideration of the major components of the diffusion tensor revealed several patterns
of WM integrity changes in the presymptomatic AD group. A predominant pattern was
reduced FA in the absence of mean diffusivity (MD) differences. Only a small portion of the
ILF/IFOF and genu showed the combined pattern of decreased FA and increased MD. The
absence of MD differences within regions of decreased FA suggests mild microstructural
loss without gross tissue loss (Sen and Basser, 2005), a result which converges with our
findings of equivalent hippocampal and entorhinal volumes between risk groups. The
absence of MD differences in regions of decreased FA in presymptomatic AD contrasts with
findings from studies of symptomatic AD, in which FA and MD are often negatively
correlated (Fellgiebel et al., 2004; Medina et al., 2006; Zhang et al., 2007). Our results
suggest that FA and MD are not necessarily correlated and that FA changes can be observed
in the absence of MD changes associated with gross tissue loss.
A second pattern of WM integrity changes in the presymptomatic group was revealed
through joint analyses of FA and component (axial and radial) diffusivities. Results revealed
that the majority of FA reductions in the high risk group were not solely driven by either
axial diffusivity (DA) or radial diffusivity (DR) changes alone. Regions showing decreased
FA in the high risk group not solely driven by alterations in either DA or DR alone included
a caudal portion of the fornix, periventricular regions and a portion of the ILF. Reductions in
FA not solely driven by either DA or DR changes alone, in regions where MD is not
increased, may reflect a subtle mixture of axonal and myelin damage, possibly resulting
from minor loss of fibers and their surrounding myelin sheath (Sen and Basser, 2005;
Burzynska et al., 2009). In addition to such potential microstructural changes, the pattern of
reduced FA not solely driven by either DA or DR changes alone may also reflect voxel-level
macrostructural variables such as decreased coherence in the orientation of axons (Bennett
et al., 2010).
In WM tracts where changes in component diffusivities were noted, they were primarily
characterized by increased DR in the presymptomatic AD group. Regions showing
decreased FA and increased DR were the cingulum, a portion of the ILF, and portions of the
IFOF. The pattern of decreased FA along with increased DR has been linked with loss of
myelin in multiple sclerosis (Ciccarelli et al., 2006) and in animal studies of experimentally
induced myelin loss (Song et al., 2002, 2005; Sun et al., 2006). The present pattern of DTI-
based findings is would appear to be consistent with data demonstrating that myelin and its
components such as cholesterol and myelin proteins are reduced early in the AD process
(Han et al., 2002; Roher et al., 2002) and with a growing body of data suggesting that
disruption of myelin integrity may be among the earliest events in the process of AD
(Bartzokis, 2009). Based on this evidence, Bartzokis has proposed a model which
reconceptualizes AD as initially a disease of demyelination, with classic amyloid beta and
tau pathologies seen as by-products of the resulting homeostatic repair processes. The
present findings of increased DR in the absence of changes in MD or MTL structural
atrophy would appear to be consistent with DTI-based predictions that could be generated
from the Bartzokis (2009) myelin hypothesis of AD.
The present study is the first to explore the DTI metrics FA/MD/DA/DR across the entire
brain in presymptomatic AD. It is thus relevant to compare our findings with the few studies
that have explored these DTI metrics across the brain in symptomatic AD (Acosta-
Cabronero et al., 2010; Bosch et al., in press; Salat et al., 2010; Stricker et al., 2009). In
contrast to the present results in presymptomatic AD, each of the symptomatic AD studies
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except that of Stricker et al. (2009) reported that WM integrity reductions included increases
in DA (in addition to DR increases). Of particular relevance was the study by Bosch et al.
(in press), which included an MCI group in addition to AD and normal senior groups. These
authors reported that, whereas both patient groups showed DR increases compared to a
normal group, only the AD group showed DA increases. Taken together, the present
findings and those from AD studies are consistent with suggestions that increased DA may
occur at a relatively late stage of WM damage, possibly when ‘cellular debris’ is cleared by
microglia (Concha et al., 2006; @@Sun et al., 2008). Of relevance, in contrast to the present
results, the prior studies reporting increased DA also reported decreased MTL volume in
symptomatic AD (Acosta-Cabronero et al., 2010; Bosch et al., in press; Salat et al., 2010).
An important topic for future research will be to determine the timing of significant DA
changes and their relationship to MTL volume during the course of AD.
At first pass, our findings would appear to be inconsistent with the possibility that Wallerian
degeneration represents the primary mechanism of decreased WM integrity preceding AD.
Wallerian degeneration secondary to distal cortical atrophy would be most clearly supported
by findings of reduced volume of MTL regions, increased MD and altered DA. This pattern
of results was not observed in our study. Instead, in the present study, the high AD-risk
group showed no evidence of MTL degeneration and minimal evidence of gross tissue loss
associated with increased MD. Similarly, the high AD-risk group showed only a few
scattered voxels in which DA was altered compared to the low risk group. However, it is
important to note that any specific conclusion about neurobiological mechanism underlying
DTI-based WM declines remain speculative at this point. The DTI technique does not yet
provide an unequivocal link to specific neurobiological mechanisms. Thus, it is not yet
possible to definitively identify mechanisms such as ‘demyelination,’ or ‘axonal
degeneration’ from DTI data (see Wheeler-Kingshott and Cercignani, 2009 and Hui et al.,
2010 for relevant discussions).
Another reason for caution with respect to conclusions of demyelination or axonal
degeneration from DTI data is that reduced WM integrity may in part reflect neuronal
dysfunction. For example, we believe that the pattern of WM alterations observed in our
study could be due to faulty communication between neuron and oligodendrocyte. Faulty
communication could be mediated from the axonal side due to neuronal dysfunction, even in
the absence of gross cortical atrophy. This possibility takes into account the concept that the
axon and enveloping central myelin make up a unit integrated via intracellular signaling.
The signaling scheme between axons and investing glia, particularly oligodendroglia in the
CNS, is not yet well defined (Nave and Trapp, 2008). However, in the peripheral nervous
system axonal signals are required for myelin maintenance, including PrPc a putative
receptor for beta-amyloid (Bremer et al., 2010). Alterations in DR from myelin disruption in
tracts projecting from pathologically involved areas could be reporting neuronal dysfunction
through this mechanism at a very early stage, before volume changes are detectable in grey
matter.
The present study has several limitations. First, as with other presymptomatic studies, a
future clinical diagnosis of AD cannot yet be confirmed. The first step in the validation of
the current findings will be to follow these currently normal study subjects longitudinally to
determine which of the observed WM microstructural alterations are most predictive of later
clinically diagnosed MCI or AD. The conversion to MCI/AD is likely to be associated with
multiple pathophysiologic mechanisms. Macrostructural degeneration of MTL structures is
clearly among the important mechanisms. In addition, structural WM disconnection has
been shown to contribute to age-related cognitive declines (Madden et al., 2004, 2009; Gold
et al., 2010) and thus may also contribute to cognitive decline associated with the onset of
MCI/AD. In particular, the continued loss of anatomical connectivity between MTL
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structures and posterior cingulate-retrosplenial cortices (i.e., further WM integrity reductions
in the caudal cingulum tract) may be of special relevance given the importance of MTL and
retrosplenial regions in memory processes (Vann et al., 2009).
Another caveat common to cross-sectional studies is that results could have been influenced
by factors other than the variable of interest alone (in this case AD-risk). Although groups
were carefully matched on a wide range of demographic, neuropsychological and medical
health characteristics, it is possible that they differed in some other unknown way for which
we could not adjust or control. Finally, we are not yet able to definitively link the observed
WM alterations with specific underlying pathologies. Although different DTI-based
diffusivity patterns have been linked with unique underlying pathologies in previous studies,
we have no independent verification of pathology (e.g., by autopsy or brain biopsy) in our
participants.
In conclusion, our results demonstrate DTI-based reductions in anatomical connectivity
between neocortical and MTL allocortical regions in presymptomatic AD in the absence of
detectable macrostructural MTL degeneration. The primary pattern of DTI results suggests
that degeneration of WM tracts in presymptomatic AD appears to be associated with subtle
decreases in axonal/myelin integrity. In a smaller number of tracts, WM reductions were
characterized by decreased FA and increased DR, raising the possibility that a myelin-
related pathology could precede frank AD in some WM pathways.
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Glossary
Abbreviations
MMSE Mini Mental State Examination
LM Imm Logical Memory Immediate
LM Delay Logical Memory Delayed
VR Imm Visual Reproduction Immediate
VR Delay Visual Reproduction Delayed
Block Des Block Design
BNT 15 item Boston Naming Test
SRT Imm Selective Reminding Test Immediate
SRT Delay Selective Reminding Test Delayed
Trails B - A score on Trials B minus score on Trails A (to assess executive functioning
after controlling for motor speed)
SS Spatial Span
Vocab Vocabulary
DS Digit Span
LF FAS Letter Fluency
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Figure 1.
Mean hippocampal and entorhinal cortex volumes in normal high and low AD-risk groups.
Volumes are normalized as a percentage of intracranial volume (ICV) for visualization
purposes. Bars represent the standard error of the mean.
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Figure 2.
Regions of decreased fractional anisotropy and increased mean diffusivity in normal, high-
AD risk subjects. The anatomic underlay used for illustration is the MNI-space registered
target fractional anisotropy (FA) image. The registered average FA skeleton is represented
in green. Regions of decreased FA are displayed in red. Regions of decreased FA and
increased mean diffusivity (MD) are displayed in orange. The numbers in front of horizontal
sections represent z coordinates in MNI space.
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Figure 3.
Regions of decreased FA and altered radial or axial diffusivity in normal, high-AD risk
subjects. The anatomic underlay and registered average FA skeleton are described in the
Figure 1 legend. Regions of decreased FA are displayed in red. Regions of decreased FA
and increased DR are displayed in dark blue. Regions of decreased FA and decreased DA
are displayed in yellow. The numbers in front of horizontal sections represent z coordinates
in MNI space.
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Figure 4.
Regions of decreased FA and altered radial or axial diffusivity in normal, high-AD risk
subjects after controlling for hippocampal volume. The anatomic underlay and registered
average FA skeleton are described in the Figure 1 legend. The left panel displays a coronal
slice when only age was included as a covariate (as in results from Figures 2 and 3). The
right panel displays the same coronal slice when normalized hippocampal volume, in
addition to age, was included as a covariate. The numbers below the coronal sections
represent y coordinates in MNI space. Controlling for hippocampal volume revealed an
additional region of decreased FA and increased DR in the caudal portion of the cingulum.
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